Valneva (VALN)

• Market cap: $847M
• 1 day: -0.71%
• 5 days: -7.11%
• 1 month: -3.45%
• 3 months: 57.3%
• 6 months: 43.91%
• Year to date: 107.63%
• 1 year: 64.71%
• 5 years: -65.43%
• 10 years: -65.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Employees: 713